Profile for Australia Patent: 2019290337
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Australia Patent: 2019290337
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,975,046 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| 11,365,182 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| 11,801,226 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| 11,802,115 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| 12,091,394 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| 12,508,234 | Jun 20, 2039 | Ipsen | BYLVAY | odevixibat |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
